CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Net Sales	$ 198	$ 24
Operating Expenses
Cost of revenues	104	0
Research and development (net of settlement of trade debt of $15,000 for the year ended December 31, 2011)	336	237
Inventory impairment expense	0	624
Fixed asset impairment expense	0	27
Selling, general and administrative (net of adjustment of trade debt of $546,000 for the year ended December 31, 2012)	1,027	1,715
Total cost and expenses	1,467	2,603
Operating Loss	(1,269)	(2,579)
Other Income (Expense):
Interest expense	(14)	(13)
Interest expense - related party	(231)	(173)
Legal settlement expense	0	(141)
Benefit from derivative liability	0	30
Total other income (expense)	(245)	(297)
Loss from operations before income taxes	(1,514)	(2,876)
Income taxes	0	0
Net Loss	(1,514)	(2,876)
Preferred stock dividends - unpaid and undeclared	(266)	(266)
Net loss applicable to common stockholders	$ (1,780)	$ (3,142)
Basic and fully diluted net loss per common share	$ (0.02)	$ (0.05)
Weighted average number of common shares outstanding	72,224,186	58,223,600